Xiaoyu Hu

Affiliations: 
University of Rochester, Rochester, NY 
Google:
"Xiaoyu Hu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hu X, Zhao M, Bai M, et al. (2024) PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutation. Cancer Letters. 216676
Liu C, Li X, Huang Q, et al. (2023) Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. Signal Transduction and Targeted Therapy. 8: 44
Shen X, Zhang B, Hu X, et al. (2022) and inhibited oral squamous cell carcinomas by regulating genome stability. Bioengineered. 13: 14094-14106
Hu X, Li L, Eid JE, et al. (2022) IDH1 Mutation Induces HIF-1 and Confers Angiogenic Properties in Chondrosarcoma JJ012 Cells. Disease Markers. 2022: 7729968
Wang L, Gao Y, Zhang G, et al. (2020) Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade. Science Translational Medicine. 12
Xiao Z, Chang L, Kim J, et al. (2019) USP37 is a SNAI1 deubiquitinase. American Journal of Cancer Research. 9: 2749-2759
Li L, Hu X, Trent JC. (2019) Depletion of mutant IDH1 impairs chondrosarcoma growth by downregulating integrins. Journal of Clinical Oncology. 37: 11031-11031
Chu Y, Wang Y, Peng W, et al. (2018) STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis. Biochemical and Biophysical Research Communications
Zhou Z, Zhang P, Hu X, et al. (2017) USP51 promotes deubiquitination and stabilization of ZEB1. American Journal of Cancer Research. 7: 2020-2031
Zhang Y, Xu W, Guo H, et al. (2017) NOTCH1 Signaling Regulates Self-renewal and Platinum Chemoresistance of Cancer Stem-like Cells in Human Non-small Cell Lung Cancer. Cancer Research
See more...